Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if a medication that increases levels of a brain
chemical called acetylcholine will improve balance and reduce falls in patients with
parkinson's disease who have the problem of very poor balance and are frequently falling or
nearly falling on a daily basis. Donepezil, a drug approved for the treatment of Alzheimer's
dementia, will reduce falls in subjects with Parkinson's disease and balance impairment.